Migraine and subsequent head and neck cancer: A nationwide population-based cohort study

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Migraine and subsequent head and neck cancer : A nationwide population-based cohort study. / Wang, Li-Tzu; Chiang, Ping-Hao; Chung, Chi-Hsiang; Song, Mingyang; Ashina, Sait; Chien, Wu-Chien; Ma, Kevin Sheng-Kai.

I: Oral Diseases, Bind 30, Nr. 4, 2024, s. 2122-2135.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Wang, L-T, Chiang, P-H, Chung, C-H, Song, M, Ashina, S, Chien, W-C & Ma, KS-K 2024, 'Migraine and subsequent head and neck cancer: A nationwide population-based cohort study', Oral Diseases, bind 30, nr. 4, s. 2122-2135. https://doi.org/10.1111/odi.14704

APA

Wang, L-T., Chiang, P-H., Chung, C-H., Song, M., Ashina, S., Chien, W-C., & Ma, K. S-K. (2024). Migraine and subsequent head and neck cancer: A nationwide population-based cohort study. Oral Diseases, 30(4), 2122-2135. https://doi.org/10.1111/odi.14704

Vancouver

Wang L-T, Chiang P-H, Chung C-H, Song M, Ashina S, Chien W-C o.a. Migraine and subsequent head and neck cancer: A nationwide population-based cohort study. Oral Diseases. 2024;30(4):2122-2135. https://doi.org/10.1111/odi.14704

Author

Wang, Li-Tzu ; Chiang, Ping-Hao ; Chung, Chi-Hsiang ; Song, Mingyang ; Ashina, Sait ; Chien, Wu-Chien ; Ma, Kevin Sheng-Kai. / Migraine and subsequent head and neck cancer : A nationwide population-based cohort study. I: Oral Diseases. 2024 ; Bind 30, Nr. 4. s. 2122-2135.

Bibtex

@article{676a82ea7d114eb1aa5c601d092d8ee4,
title = "Migraine and subsequent head and neck cancer: A nationwide population-based cohort study",
abstract = "Objectives: The association of migraine with the risk of certain cancer has been reported. The aim of this pilot study was to examine the associations between migraine and the onset of head and neck cancers (HNC). Materials and Methods: A total of 1755 individuals were identified through a nationwide population-based cohort registry in Taiwan between 2000 and 2013. The primary end point variable was new-onset head and neck cancers in patients with migraine versus non-migraine controls. Cox proportional hazard regression was used to derive the risk of HNC. Subgroup analyses were performed to determine subpopulations at risk of migraine-associated HNC. Sub-outcome analyses were carried out to provide the subtypes of migraine-associated HNC. Propensity score matching was utilized to validate the findings. Results: A total of four patients out of 351 patients with migraine and seven out of 1404 non-migraine controls developed HNC. The incidence of HNC was higher in patients with migraine than that in non-migraine controls (108.93 vs. 48.77 per 100,000 person-years) (adjusted hazard ratio, aHR = 2.908, 95% CI = 0.808–10.469; p = 0.102). The risk of HNC in patients with migraine with aura (aHR = 5.454, 95% CI = 0.948–26.875; p = 0.264) and without aura (aHR = 2.777, 95% CI = 0.755–8.473; p = 0.118) was revealed. The incidence of non-nasopharyngeal HNC secondary to migraine (112.79 per 100,000 person-years) was higher than that of nasopharyngeal cancer secondary to migraine (105.33 per 100,000 person-years). Conclusion: A higher incidence of HNC was observed in a small sample of patients with migraine, especially in those with migraine with aura. Migraine-associated HNC included non-nasopharyngeal HNC. Studies with a larger sample are needed to confirm the finding of the high risk of HNC in people with migraine.",
keywords = "cohort study, epidemiology, head and neck cancer, headache, migraine, migraine with aura, oral cancer",
author = "Li-Tzu Wang and Ping-Hao Chiang and Chi-Hsiang Chung and Mingyang Song and Sait Ashina and Wu-Chien Chien and Ma, {Kevin Sheng-Kai}",
note = "Publisher Copyright: {\textcopyright} 2023 Wiley Periodicals LLC.",
year = "2024",
doi = "10.1111/odi.14704",
language = "English",
volume = "30",
pages = "2122--2135",
journal = "Oral Diseases",
issn = "1354-523X",
publisher = "Wiley-Blackwell",
number = "4",

}

RIS

TY - JOUR

T1 - Migraine and subsequent head and neck cancer

T2 - A nationwide population-based cohort study

AU - Wang, Li-Tzu

AU - Chiang, Ping-Hao

AU - Chung, Chi-Hsiang

AU - Song, Mingyang

AU - Ashina, Sait

AU - Chien, Wu-Chien

AU - Ma, Kevin Sheng-Kai

N1 - Publisher Copyright: © 2023 Wiley Periodicals LLC.

PY - 2024

Y1 - 2024

N2 - Objectives: The association of migraine with the risk of certain cancer has been reported. The aim of this pilot study was to examine the associations between migraine and the onset of head and neck cancers (HNC). Materials and Methods: A total of 1755 individuals were identified through a nationwide population-based cohort registry in Taiwan between 2000 and 2013. The primary end point variable was new-onset head and neck cancers in patients with migraine versus non-migraine controls. Cox proportional hazard regression was used to derive the risk of HNC. Subgroup analyses were performed to determine subpopulations at risk of migraine-associated HNC. Sub-outcome analyses were carried out to provide the subtypes of migraine-associated HNC. Propensity score matching was utilized to validate the findings. Results: A total of four patients out of 351 patients with migraine and seven out of 1404 non-migraine controls developed HNC. The incidence of HNC was higher in patients with migraine than that in non-migraine controls (108.93 vs. 48.77 per 100,000 person-years) (adjusted hazard ratio, aHR = 2.908, 95% CI = 0.808–10.469; p = 0.102). The risk of HNC in patients with migraine with aura (aHR = 5.454, 95% CI = 0.948–26.875; p = 0.264) and without aura (aHR = 2.777, 95% CI = 0.755–8.473; p = 0.118) was revealed. The incidence of non-nasopharyngeal HNC secondary to migraine (112.79 per 100,000 person-years) was higher than that of nasopharyngeal cancer secondary to migraine (105.33 per 100,000 person-years). Conclusion: A higher incidence of HNC was observed in a small sample of patients with migraine, especially in those with migraine with aura. Migraine-associated HNC included non-nasopharyngeal HNC. Studies with a larger sample are needed to confirm the finding of the high risk of HNC in people with migraine.

AB - Objectives: The association of migraine with the risk of certain cancer has been reported. The aim of this pilot study was to examine the associations between migraine and the onset of head and neck cancers (HNC). Materials and Methods: A total of 1755 individuals were identified through a nationwide population-based cohort registry in Taiwan between 2000 and 2013. The primary end point variable was new-onset head and neck cancers in patients with migraine versus non-migraine controls. Cox proportional hazard regression was used to derive the risk of HNC. Subgroup analyses were performed to determine subpopulations at risk of migraine-associated HNC. Sub-outcome analyses were carried out to provide the subtypes of migraine-associated HNC. Propensity score matching was utilized to validate the findings. Results: A total of four patients out of 351 patients with migraine and seven out of 1404 non-migraine controls developed HNC. The incidence of HNC was higher in patients with migraine than that in non-migraine controls (108.93 vs. 48.77 per 100,000 person-years) (adjusted hazard ratio, aHR = 2.908, 95% CI = 0.808–10.469; p = 0.102). The risk of HNC in patients with migraine with aura (aHR = 5.454, 95% CI = 0.948–26.875; p = 0.264) and without aura (aHR = 2.777, 95% CI = 0.755–8.473; p = 0.118) was revealed. The incidence of non-nasopharyngeal HNC secondary to migraine (112.79 per 100,000 person-years) was higher than that of nasopharyngeal cancer secondary to migraine (105.33 per 100,000 person-years). Conclusion: A higher incidence of HNC was observed in a small sample of patients with migraine, especially in those with migraine with aura. Migraine-associated HNC included non-nasopharyngeal HNC. Studies with a larger sample are needed to confirm the finding of the high risk of HNC in people with migraine.

KW - cohort study

KW - epidemiology

KW - head and neck cancer

KW - headache

KW - migraine

KW - migraine with aura

KW - oral cancer

U2 - 10.1111/odi.14704

DO - 10.1111/odi.14704

M3 - Journal article

C2 - 37551839

AN - SCOPUS:85167364686

VL - 30

SP - 2122

EP - 2135

JO - Oral Diseases

JF - Oral Diseases

SN - 1354-523X

IS - 4

ER -

ID: 372572609